Pharma funds have remained laggards among sectoral funds despite a sharp rally in pharma stocks last year in the aftermath of the Covid-19 outbreak. These funds have shed 3 per cent during the last three months and have gained 29 per cent in a year even as the NSE Nifty Pharma index has shed 2.6 per cent and gained 25 per cent.
Financial Terms Like Mutual Fund, IPO and Bond Now In Sign Language For Differently-Abled
Read More